Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX0LRE
|
||||
Drug Name |
2-cyano-4-cyclohexylamino-pyrimidine-5-carboxylic acid [2-(3-methoxyphenyl)-ethyl]-amide
|
||||
Synonyms |
CHEMBL385632
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C21H25N5O2
|
||||
Canonical SMILES |
COc1cccc(CCNC(=O)c2cnc(nc2NC3CCCCC3)C#N)c1
|
||||
InChI |
InChI=1S/C21H25N5O2/c1-28-17-9-5-6-15(12-17)10-11-23-21(27)18-14-24-19(13-22)26-20(18)25-16-7-3-2-4-8-16/h5-6,9,12,14,16H,2-4,7-8,10-11H2,1H3,(H,23,27)(H,24,25,26)
|
||||
InChIKey |
YZBDFADJOLGKFN-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.